A general form of covariate adjustment in clinical trials under covariate-adaptive randomization
In randomized clinical trials, adjusting for baseline covariates can improve credibility and efficiency for demonstrating and quantifying treatment effects. This article studies the augmented inverse propensity weighted estimator, which is a general form of covariate adjustment that uses linear, generalized linear and nonparametric or machine learning models for the conditional mean of the response given covariates. Under covariate-adaptive randomization, we establish general theorems that show a complete picture of the asymptotic normality, efficiency gain and applicability of augmented inverse propensity weighted estimators. In particular, we provide for the first time a rigorous theoretical justification of using machine learning methods with cross-fitting for dependent data under covariate-adaptive randomization. Based on the general theorems, we offer insights on the conditions for guaranteed efficiency gain and universal applicability under different randomization schemes, which also motivate a joint calibration strategy using some constructed covariates after applying augmented inverse propensity weighted estimators.
Authors
- Marlena S. Bannick (ORCID: https://orcid.org/0000-0001-6279-5978)
- Yanyao Yi (ORCID: https://orcid.org/0000-0003-1540-1862)
- Jingyi Liu (ORCID: https://orcid.org/0000-0002-9985-7068)
- Yu Du (ORCID: https://orcid.org/0000-0002-3263-0141)
- Ting Ye (ORCID: https://orcid.org/0000-0001-6009-641X)
- Jun Shao (ORCID: https://orcid.org/0000-0002-6239-4258)
Institutions
- University of Wisconsin–Madison (US)
- Eli Lilly (United States) (US)
- University of Washington (US)
Publication Details
- Journal
- Biometrika
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/biomet/asaf029
- Citations
- 4
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 13.15
Funders
- National Institutes of Health